Based on the structure–activity relationship, withaferin A, 3-aziridinylwithaferin A, withanolide E, and 4-hydroxywithanolide E are directly bound to HSP90 and inhibit HSP90 activity from inactivating AKT in pancreatic cancer cells [139]. Here, AKT1 is linked to familial pancreatic carcinoma.